adalimumab

Uses• rheumatoid arthritis
• inflammatory bowel disease (Crohn disease; ulcerative colitis)
Contraindications,
drug interactions
or cautions
Contraindications
• hypersensitivity to adalimumab, tuberculosis, opportunistic infection, sepsis, moderate-to-severe heart failure (NYHA class III/IV)
Drug interactions
• abatacept, belimumab, certolizumab, infliximab, natalizumab, tacrolimus
Cautions
• patients should be evaluated for latent tuberculosis infection with a tuberculin skin test prior to therapy.
• treatment of latent tuberculosis should be initiated before use.
Adverse Effects (common and severe)• headache
• skin rash
• upper respiatory tract infection
• sinusitis
• tuberculosis
• malignancy
Instructions and dose
(initial; typical)
indication-specific dosing (rheumatoid arthritis: 40 mg every other week subcutaneously; inflammatory bowel disease: 160 mg given as four 40 mg injections on day 1 or given as two 40 mg injections per day over 2 consecutive days)
Monitoring• signs and symptoms of active infection (including tuberculosis)
• complete blood count with differential
• signs/symptoms/worsening of heart failure
Source of Suggestion
Commonly prescribed medication
(Added on August, 2016)